Literature DB >> 6491365

Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases.

C G Helmick, K W Bernard, L J D'Angelo.   

Abstract

Most previous reports of Rocky Mountain spotted fever (RMSF) have included cases either not laboratory confirmed or confirmed by relatively weak diagnostic criteria. In the present study detailed epidemiological, clinical, and laboratory features of 262 confirmed or highly probable cases of RMSF reported from six states from 1977 to 1980 were analyzed. This analysis revealed that early clinical diagnosis of RMSF is difficult because the illness may have a gradual or an abrupt onset, the symptoms and signs may be unusual in timing or frequency, and the clinical appearance may vary depending on such factors as age and location of residence. RMSF was diagnosed later in those who died than in survivors, primarily because of atypical initial symptoms and the late onset of rash. RMSF should be considered in any individual who, during the spring and summer, has been in RMSF-endemic areas and develops a fever, regardless of the absence of rash or history of tick exposure.

Entities:  

Mesh:

Year:  1984        PMID: 6491365     DOI: 10.1093/infdis/150.4.480

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

Review 1.  Clinical manifestations of tick-borne infections in children.

Authors:  K A Bryant; G S Marshall
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 2.  Host, pathogen and treatment-related prognostic factors in rickettsioses.

Authors:  E Botelho-Nevers; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-26       Impact factor: 3.267

3.  Comparison of immunofluorescence, Western blotting, and cross-adsorption assays for diagnosis of African tick bite fever.

Authors:  Mogens Jensenius; Pierre-Edouard Fournier; Sirkka Vene; Signe Holta Ringertz; Bjørn Myrvang; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

4.  The Rickettsia conorii autotransporter protein Sca1 promotes adherence to nonphagocytic mammalian cells.

Authors:  Sean P Riley; Kenneth C Goh; Timothy M Hermanas; Marissa M Cardwell; Yvonne G Y Chan; Juan J Martinez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

5.  Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Davidson; D P Aucoin; M G Levy; N S Szabados; B C Hegarty; A L Kuehne; R L James
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

6.  Rocky Mountain Spotted Fever and Pregnancy: Four Cases from Sonora, Mexico.

Authors:  Jesus David Licona-Enriquez; Jesus Delgado-de la Mora; Christopher D Paddock; Carlos Arturo Ramirez-Rodriguez; María Del Carmen Candia-Plata; Gerardo Álvarez Hernández
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

7.  Pathogenic Rickettsia species acquire vitronectin from human serum to promote resistance to complement-mediated killing.

Authors:  Sean P Riley; Jennifer L Patterson; Samantha Nava; Juan J Martinez
Journal:  Cell Microbiol       Date:  2013-12-13       Impact factor: 3.715

8.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Evidence for a high prevalence of spotted fever group rickettsial infections in diverse ecologic zones of Inner Mongolia.

Authors:  Q H Liu; G Y Chen; Y Jin; M Te; L C Niu; S P Dong; D H Walker
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

10.  In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin.

Authors:  M Drancourt; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.